ストックスクリーナーアプリを入手
12.91
1.97%
0.25
前日終値:
$12.66
開ける：
$12.73
24時間の取引高:
1.84M
Relative Volume:
0.87
時価総額：
$1.77B
収益：
$249.70M
当期純損益:
$17.18M
株価収益率:
33.10
EPS:
0.39
ネットキャッシュフロー:
$35.33M
1週間 パフォーマンス:
+6.08%
1か月 パフォーマンス:
+20.54%
6か月 パフォーマンス:
+13.35%
1年 パフォーマンス:
-5.28%
1日の値動き範囲:
$12.67
$12.99
1週間の範囲:
$12.11
$12.99
52週間の値動き範囲:
$9.74
$15.01
Dynavax Technologies Corp Stock (DVAX) Company Profile
名前
Dynavax Technologies Corp
セクター
電話
(510) 848-5100
住所
2100 POWELL STREET, EMERYVILLE, CA
DVAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
12.91 | 1.77B | 249.70M | 17.18M | 35.33M | 0.39 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-02-01 | 開始されました | Goldman | Neutral |
| 2022-09-27 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-01-06 | 再開されました | Goldman | Buy |
| 2021-08-06 | 開始されました | Goldman | Buy |
| 2020-08-07 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-15 | 開始されました | Evercore ISI | Outperform |
| 2019-10-18 | 開始されました | H.C. Wainwright | Buy |
| 2019-07-11 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2019-02-27 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-05-10 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-03-08 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-02-14 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2017-09-25 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-09-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-07-31 | アップグレード | JP Morgan | Neutral → Overweight |
| 2017-07-31 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-05-09 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-04-28 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2016-04-27 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2015-11-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2013-11-25 | アップグレード | MLV & Co | Hold → Buy |
| 2013-02-25 | ダウングレード | MLV & Co | Buy → Hold |
| 2012-11-16 | 繰り返されました | MLV & Co | Buy |
すべてを表示
Dynavax Technologies Corp (DVAX) 最新ニュース
Does Dynavax Technologies (DVAX) Have the Potential to Rally 93.52% as Wall Street Analysts Expect? - Yahoo Finance
Great Point Partners LLC Reduces Holdings in Dynavax Technologies Co. (NASDAQ:DVAX) - MarketBeat
Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't? - Yahoo Finance
Principal Financial Group Inc. Has $6.44 Million Holdings in Dynavax Technologies Co. (NASDAQ:DVAX) - MarketBeat
Dynavax Technologies’ $200M Share Buyback: Potential Risks and Financial Implications - MSN
Dynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To Explode - Insider Monkey
Amalgamated Bank Decreases Stake in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Mizuho Markets Americas LLC Has $15.37 Million Position in Dynavax Technologies Co. (NASDAQ:DVAX) - MarketBeat
Entropy Technologies LP Invests $462,000 in Dynavax Technologies Co. (NASDAQ:DVAX) - MarketBeat
Dynavax Technologies (NASDAQ:DVAX) Stock Price Down 7.8%Here's What Happened - MarketBeat
Dynavax Technologies Corp (NASDAQ: DVAX): Blank Check On Growth? - Stocks Register
Kynam Capital Management, LP Increases Stake in Dynavax Technolo - GuruFocus.com
Dynavax Technologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Dynavax's SWOT analysis: hepatitis B vaccine maker's stock poised for growth - Investing.com Australia
Dynavax's SWOT analysis: hepatitis B vaccine maker's stock poised for growth By Investing.com - Investing.com South Africa
U.S. STOCKS Home Depot, MeridianLink, Dynavax - XM
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why - Yahoo Finance
Wall Street Analysts Predict an 88.32% Upside in Dynavax Technologies (DVAX): Here's What You Should Know - Yahoo Finance
Dynavax enters $100M accelerated share repurchase agreement - MSN
Dynavax Launches $100M Share Buyback Deal with Goldman Sachs, Signals Strong Confidence | DVAX Stock News - StockTitan
William Blair Has Positive Outlook of DVAX FY2024 Earnings - MarketBeat
HC Wainwright Has Bullish Estimate for DVAX FY2024 Earnings - MarketBeat
Dynavax Technologies Corporation Just Recorded A 9.1% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
Mawson Infrastructure Group (OTCMKTS:WIZP) & Dynavax Technologies (NASDAQ:DVAX) Head-To-Head Survey - Defense World
Dynavax Technologies (NASDAQ:DVAX) Shares Up 13.3%What's Next? - MarketBeat
Dynavax Technologies Corporation (NASDAQ:DVAX) Q3 2024 Earnings Call Transcript - Insider Monkey
Dynavax Technologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Dynavax Technologies Corp (DVAX) Q3 2024 Earnings Call Highlights: Record Hep B Sales and ... By GuruFocus - Investing.com Canada
Dynavax Technologies Corp (DVAX) Trading 11.36% Higher on Nov 8 - GuruFocus.com
Dynavax rises 11% on Q3 bottom line beat, 2024 positive net income expectation - MSN
Dong Yu Joins in Dynavax Technologies Corporation as Senior Vice President of Vaccine Research and A Member of the Executive Team - Marketscreener.com
Dynavax Technologies Corporation Updates Earnings Guidance for the Year 2024 - Marketscreener.com
HC Wainwright Reiterates "Buy" Rating for Dynavax Technologies (NASDAQ:DVAX) - MarketBeat
Dynavax Technologies: Q3 Earnings Snapshot - The Washington Post
Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript - Yahoo Finance
Dynavax Technologies (DVAX) Q3 Earnings Surpass Estimates - Yahoo Finance
Dynavax approves $200 million stock buyback plan - Investing.com
Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX) - Marketscreener.com
Insights into Dynavax Technologies's Upcoming Earnings - Benzinga
AlphaCentric Advisors LLC Raises Holdings in Dynavax Technologies Co. (NASDAQ:DVAX) - MarketBeat
Dynavax Technologies (DVAX) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Dynavax Technologies adopts limited-duration stockholder rights plan - MSN
Dynavax Technologies Breaks Above 200-Day Moving AverageBullish for DVAX - Nasdaq
Dynavax adopts stockholder rights plan amid stake buildu - Investing.com
Dynavax Adopts Limited-Duration Stockholder Rights Plan - PR Newswire
744,282 Shares in Dynavax Technologies Co. (NASDAQ:DVAX) Purchased by Assenagon Asset Management S.A. - MarketBeat
Deep Track Capital, LP Reduces Stake in Dynavax Technologies Cor - GuruFocus.com
Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024 - StockTitan
Dynavax Technologies Corp. (NASDAQ: DVAX) Gains 0.09% In Early Trade; What Lies Ahead? - Stocks Register
Dynavax Technologies Co. (NASDAQ:DVAX) Shares Sold by Chicago Capital LLC - MarketBeat
Dynavax Technologies Corp (DVAX) Stock Price Up 3.21% on Oct 16 - GuruFocus.com
Dynavax Technologies Corp (DVAX) 財務データ
収益
当期純利益
現金流量
EPS
Dynavax Technologies Corp (DVAX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| CANO FRANCIS | Director |
May 24 '24 |
Option Exercise |
5.90 |
7,500 |
44,250 |
44,405 |
| Burgess Justin | Chief Accounting Officer |
Mar 01 '24 |
Option Exercise |
10.45 |
7,101 |
74,232 |
20,526 |
| Burgess Justin | Chief Accounting Officer |
Mar 01 '24 |
Sale |
12.78 |
20,526 |
262,322 |
0 |
| Janssen Robert | SVP and CMO |
Jan 04 '24 |
Option Exercise |
9.41 |
1,500 |
14,115 |
51,425 |
| Janssen Robert | SVP and CMO |
Jan 04 '24 |
Sale |
15.00 |
1,500 |
22,500 |
49,925 |
| Novack David F | President & COO |
Jan 02 '24 |
Option Exercise |
5.42 |
9,000 |
48,780 |
12,187 |
| Novack David F | President & COO |
Jan 02 '24 |
Sale |
14.45 |
9,000 |
130,050 |
3,187 |
| Novack David F | President & COO |
Dec 01 '23 |
Option Exercise |
5.42 |
20,000 |
108,400 |
23,187 |
| Novack David F | President & COO |
Dec 01 '23 |
Sale |
13.56 |
20,000 |
271,200 |
3,187 |
0.83%
1.03%
大文字化:
|
ボリューム (24 時間):